Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
Baxter International (BAX) PT Lowered to $40 at UBS
May 3, 2024 7:03 AM EDTUBS analyst Danielle Antalffy lowered the price target on Baxter International (NYSE: BAX) to $40.00 (from $42.00) while maintaining a Neutral rating.
The analyst comments "Our modestly lower $40 PT is derived by applying a ~12x P/E multiple to our Q5-Q8 sales estimate. Our... More
Baxter International (BAX) PT Lowered to $43 at Jefferies
May 2, 2024 3:59 PM EDTJefferies analyst Matthew Taylor lowered the price target on Baxter International (NYSE: BAX) to $43.00 (from $45.00) while maintaining a Hold rating.
The analyst comments "BAX reported 1Q24 sales of $3.59B +3% xfx vs cons $3.55B and EPS of $0.65 vs cons $0.61. BAX continues to... More
